Literature DB >> 19782023

mir-210: a sensor for hypoxic stress during tumorigenesis.

Lijoy K Mathew1, M Celeste Simon.   

Abstract

In this issue of Molecular Cell, Huang et al. (2009) demonstrate that hypoxia-inducible mir-210 acts as a rheostat for cellular adaptation and survival by inhibiting tumor initiation.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19782023      PMCID： PMC2869244          DOI： 10.1016/j.molcel.2009.09.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN： 1097-2765            Impact factor:   17.970


  10 in total

1.  Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia.

Authors:  Abderrahmane Kaidi; Ann Caroline Williams; Christos Paraskeva
Journal:  Nat Cell Biol       Date:  2007-01-14       Impact factor: 28.824

2.  MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.

Authors:  Pasquale Fasanaro; Yuri D'Alessandra; Valeria Di Stefano; Roberta Melchionna; Sveva Romani; Giulio Pompilio; Maurizio C Capogrossi; Fabio Martelli
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

3.  A microRNA signature of hypoxia.

Authors:  Ritu Kulshreshtha; Manuela Ferracin; Sylwia E Wojcik; Ramiro Garzon; Hansjuerg Alder; Francisco J Agosto-Perez; Ramana Davuluri; Chang-Gong Liu; Carlo M Croce; Massimo Negrini; George A Calin; Mircea Ivan
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

4.  HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

Authors:  Minori Koshiji; Yukio Kageyama; Erin A Pete; Izumi Horikawa; J Carl Barrett; L Eric Huang
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

5.  Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

Authors:  Xin Huang; Lianghao Ding; Kevin L Bennewith; Ricky T Tong; Scott M Welford; K Kian Ang; Michael Story; Quynh-Thu Le; Amato J Giaccia
Journal:  Mol Cell       Date:  2009-09-24       Impact factor: 17.970

6.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

Authors:  Zhan Zhang; Hong Sun; Hongyue Dai; Ryan M Walsh; Maki Imakura; Janell Schelter; Julja Burchard; Xudong Dai; Aaron N Chang; Robert L Diaz; Joseph R Marszalek; Steven R Bartz; Michael Carleton; Michele A Cleary; Peter S Linsley; Carla Grandori
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

7.  Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

Authors:  Janaiah Kota; Raghu R Chivukula; Kathryn A O'Donnell; Erik A Wentzel; Chrystal L Montgomery; Hun-Way Hwang; Tsung-Cheng Chang; Perumal Vivekanandan; Michael Torbenson; K Reed Clark; Jerry R Mendell; Joshua T Mendell
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

8.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.

Authors:  John D Gordan; Jessica A Bertout; Cheng-Jun Hu; J Alan Diehl; M Celeste Simon
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

Review 9.  MicroRNAs and the hallmarks of cancer.

Authors:  T Dalmay; D R Edwards
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

Review 10.  Hypoxia-inducible factors, stem cells, and cancer.

Authors:  Brian Keith; M Celeste Simon
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582
  10 in total
  22 in total

1.  Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function.

Authors:  Ha Won Kim; Shujia Jiang; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

2.  Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.

Authors:  Matthew G Costales; Blessy Suresh; Kamalakannan Vishnu; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2019-05-23       Impact factor: 8.116

3.  Identifying and validating small molecules interacting with RNA (SMIRNAs).

Authors:  Matthew D Disney; Sai Pradeep Velagapudi; Yue Li; Matthew G Costales; Jessica L Childs-Disney
Journal:  Methods Enzymol       Date:  2019-05-15       Impact factor: 1.600

4.  Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer.

Authors:  Anvesha Srivastava; Simeng Suy; Sean P Collins; Deepak Kumar
Journal:  Mol Cell Pharmacol       Date:  2011

5.  Hypoxia, HIFs and bone development.

Authors:  Elisa Araldi; Ernestina Schipani
Journal:  Bone       Date:  2010-05-02       Impact factor: 4.398

6.  Analysis of miRNA-seq in the liver of common carp (Cyprinus carpio L.) in response to different environmental temperatures.

Authors:  JunLong Sun; LiuLan Zhao; Hao Wu; WenQiang Lian; Can Cui; ZongJun Du; Wei Luo; MingZhou Li; Song Yang
Journal:  Funct Integr Genomics       Date:  2018-11-15       Impact factor: 3.410

Review 7.  MicroRNAs in adipogenesis and as therapeutic targets for obesity.

Authors:  Ryan Alexander; Harvey Lodish; Lei Sun
Journal:  Expert Opin Ther Targets       Date:  2011-02-28       Impact factor: 6.902

8.  Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

Authors:  Kaylin M McMahon; R Kannan Mutharasan; Sushant Tripathy; Dorina Veliceasa; Mariana Bobeica; Dale K Shumaker; Andrea J Luthi; Brian T Helfand; Hossein Ardehali; Chad A Mirkin; Olga Volpert; C Shad Thaxton
Journal:  Nano Lett       Date:  2011-02-14       Impact factor: 11.189

Review 9.  OxymiRs in cutaneous development, wound repair and regeneration.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Semin Cell Dev Biol       Date:  2012-10-10       Impact factor: 7.727

10.  Role of microRNA-210 in human intervertebral disc degeneration.

Authors:  DA-Ying Zhang; Zhi-Jian Wang; Yan-Bo Yu; Yong Zhang; Xue-Xue Zhang
Journal:  Exp Ther Med       Date:  2016-03-21       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.